Merck & Co., Inc. ( MRK) - Key Metrics
MRK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $6.72 | -$0.54 | $2.17 | $1.81 |
| 2026Q1 | $6.59 | -$1.72 | $1.58 | $1.18 |
| 2025Q4 | $6.60 | $1.20 | $1.15 | $0.74 |
| 2025Q3 | $6.89 | $2.32 | $3.14 | $2.74 |
| 2025Q2 | $6.29 | $1.76 | $1.31 | $1.01 |
MRK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | -160.60% | -59.49 |
| 2026Q1 | -49.65% | -17.48 |
| 2025Q4 | 68.11% | 21.93 |
| 2025Q3 | 35.11% | 9.04 |
| 2025Q2 | 46.92% | 11.24 |
MRK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.41% | 0.67% |
| 2026Q1 | 0.98% | 0.71% |
| 2025Q4 | 0.70% | 0.77% |
| 2025Q3 | 3.26% | 0.97% |
| 2025Q2 | 1.27% | 1.05% |
MRK
Price: $150.69
Dividend Yield: 2.58%
Forward Dividend Yield: 2.23%
Payout Ratio: 57.04%
Dividend Per Share: 3.40 USD
Earnings Per Share: 1.25 USD
P/E Ratio: 104.74
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 7.8 million
Ebitda: 2.3 billionMarket Capitalization: 323.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 65
DGR3: 5.57%
DGR5: 7.12%
DGR10: 6.54%
DGR20: 4.11%